Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update

Leukemia. 2004 Nov;18(11):1924-5. doi: 10.1038/sj.leu.2403440.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • DNA (Cytosine-5-)-Methyltransferases / antagonists & inhibitors
  • Humans
  • Lymphocytes / drug effects
  • Lymphocytes / pathology*
  • Lymphoma / drug therapy*
  • Lymphoma / pathology
  • Middle Aged
  • Splenectomy
  • Splenic Neoplasms / drug therapy*
  • Splenic Neoplasms / pathology
  • Vidarabine / analogs & derivatives*
  • Vidarabine / therapeutic use*

Substances

  • Antineoplastic Agents
  • DNA (Cytosine-5-)-Methyltransferases
  • Vidarabine
  • fludarabine